PKT2/CLP-AKT Citations (3)

Originally described in: De novo induction of genetically engineered brain tumors in mice using plasmid DNA.
Wiesner SM, Decker SA, Larson JD, Ericson K, Forster C, Gallardo JL, Long C, Demorest ZL, Zamora EA, Low WC, SantaCruz K, Largaespada DA, Ohlfest JR Cancer Res. 2009 Jan 15. 69(2):431-9. PubMed Journal

---

Articles Citing PKT2/CLP-AKT

Articles
Integration of Oncogenes via Sleeping Beauty as a Mouse Model of HPV16(+) Oral Tumors and Immunologic Control. Lin YH, Yang MC, Tseng SH, Jiang R, Yang A, Farmer E, Peng S, Henkle T, Chang YN, Hung CF, Wu TC. Cancer Immunol Res. 2018 Mar;6(3):305-319. doi: 10.1158/2326-6066.CIR-16-0358. Epub 2018 Jan 23. PubMed
A novel spontaneous hepatocellular carcinoma mouse model for studying T-cell exhaustion in the tumor microenvironment. Liu YT, Tseng TC, Soong RS, Peng CY, Cheng YH, Huang SF, Chuang TH, Kao JH, Huang LR. J Immunother Cancer. 2018 Dec 7;6(1):144. doi: 10.1186/s40425-018-0462-3. PubMed
Development of a Novel Mouse Model of Spontaneous High-Risk HPVE6/E7-Expressing Carcinoma in the Cervicovaginal Tract. Henkle TR, Lam B, Kung YJ, Lin J, Tseng SH, Ferrall L, Xing D, Hung CF, Wu TC. Cancer Res. 2021 Sep 1;81(17):4560-4569. doi: 10.1158/0008-5472.CAN-21-0399. Epub 2021 Jul 2. PubMed

If you have published an article using this material, please email us at to have your article added to this page.